ARTICLE | Company News
MediVas, Merck deal
February 5, 2007 8:00 AM UTC
The companies will apply MediVas’ polyesteramide (PEA) copolymer delivery technology to undisclosed MRK oral biologics. MRK also has an exclusive option to use the technology with additional undisclos...